Key Product Insight
Cosmetic brightening via mechanical exfoliation and tyrosinase inhibition.
Low-risk cosmetic / AYUSH-adjacent scrub. Avoid therapeutic "cure" claims.
Core Ingredients
Evidence Grading
Biological Targets
Rate-limiting enzyme inhibited by Vit C
Melanocyte master regulator
Reduced via antioxidant action
Compound-Target Map
Ascorbic Acid (6%)
Tyrosinase Inhibition, ROS Quenching, MITF Modulation
Aloe Vera Polysaccharides
Barrier Support, Anti-inflammatory (IL-6, TNFα)
Phenolic Fractions (Olive/Walnut)
Oxidative Stress Reduction, Melanocyte Protection
Decentralized Clinical Trial (DCT) Strategy
Study Endpoints
- Instrumental Skin Color (L*/ITA°)
- Visual assessment of pigmentation change
- Patient-reported "Glow" (Likert 5)
Biomarkers of Interest
*MASI = Melasma Area and Severity Index. In a cosmetic study, a "MASI-like" clinician assessment is utilized.
Clinical Stratification & Monitoring
User Stratification
Low Risk / Standard Use
Non-sensitive skin, no eczema/rosacea. 2-3x weekly application.
Sensitive / Caution
History of irritation. Weekly usage with patch test at jawline.
High Risk / Avoid
Active eczema, flare, or broken skin. Avoid until cleared by derm.
Risk Mitigation
Mechanical Abrasion
Trigger: Walnut/Sugar Particles
Local Irritation
Trigger: Low pH Ascorbic Acid
Escalation Workflow (Red Flags)
Mild Effect
Stop for 1-2 weeks. Use gentle moisturizer only.
Moderate Effect
Prolonged itching/peeling. Apply cool compress & see clinic.
Severe Effect
Blistering/Swelling. Emergency Room required.